-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Bone Biologics Corp quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2014 to Q4 2024.
- Bone Biologics Corp Nonoperating Income (Expense) for the quarter ending December 31, 2024 was $33.2K.
- Bone Biologics Corp Nonoperating Income (Expense) for the twelve months ending December 31, 2024 was $107K, a 77.7% decline year-over-year.
- Bone Biologics Corp annual Nonoperating Income (Expense) for 2024 was $107K, a 77.7% decline from 2023.
- Bone Biologics Corp annual Nonoperating Income (Expense) for 2023 was $480K, a 78% decline from 2022.
- Bone Biologics Corp annual Nonoperating Income (Expense) for 2022 was $2.18M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)